scholarly journals Impact of the COVID-19 Pandemic on Cancer Patients: Challenges and Practical Approach to Management

2020 ◽  
Vol 1 (supplement) ◽  
pp. 6
Author(s):  
Uzma Azeem Awan ◽  
Rida Fatima Saeed ◽  
Muhammad Zeeshan Bhatti ◽  
Muhammad Naeem ◽  
Nosheen Akhtar
Keyword(s):  
Cancer Patients ◽  
Clinical Care ◽  
Management Strategies ◽  
Control Measures ◽  
Medical Community ◽  
Beneficial Effects ◽  
Infection Control Measures ◽  
Care Models ◽  
Current Outbreak ◽  
Cancer Intervention

The coronavirus 2019 (COVID-19) outbreak has rapidly spread worldwide, which poses great challenges to the healthcare system around the world. This pandemic has shown that globally medical community has no care- models to deal with the effects imposed on patients with chronic illnesses. Appropriate and timely diagnosis and treatment of this highly vulnerable immunocompromised population is mandatory. Prominent challenges faced during the current outbreak include resource allocation, management of patients suffering from and follow-up-phases, patient fear and protection of healthcare workers. During Pandemic, the major management strategies for cancer patients comprise education about personal protective measures, symptoms of COVID- 19, emotional support, clear communication about infection control measures and clinical care. To decrease the risk of exposure, active individualized cancer intervention is required with reduce outpatient visits and maximum telemedicine. Currently, international guidelines to manage cancer patients in any infectious pandemic are not available. The development of a complete contingency plan with guidelines for the safety and patients care will pose beneficial effects by minimizing the risks of morbidity and mortality.

scholarly journals EP.FRI.32 Emotional Resilience and Bariatric Surgical Teams: a Priorityin the Pandemic

2021 ◽  
Vol 108 (Supplement_7) ◽  
Author(s):  
Yitka Graham ◽  
Kamal Mahawar ◽  
Manel Riera ◽  
Islam Omar ◽  
Aparna Bhasker ◽  
...  
Keyword(s):  
Clinical Care ◽  
Control Measures ◽  
Multidisciplinary Teams ◽  
Health Issues ◽  
Emotional Resilience ◽  
Emotional Labour ◽  
New Ways Of Working ◽  
Infection Control Measures ◽  
Surgical Teams ◽  
Insight Into

Abstract The infection control measures implemented as a result of COVID-19 led to a postponement of bariatric surgical procedures across many countries worldwide. Many bariatric surgical teams were in essence left without a profession, with many redeployed to other areas of clinical care and were not able to provide the levels of patient support given before COVID-19. As the pandemic continues, some restrictions have been lifted, with staff adjusting to new ways of working, incorporating challenging working conditions and dealing with continuing levels of stress. This article explores the concept of emotional labour, defined as ‘inducing or suppressing feelings in order to perform one’s work’, and its application to multidisciplinary teams working within bariatric surgery, to offer insight into the mental health issues that may be affecting healthcare professionals working in this discipline.

Tracking industry responsiveness to COVID-19 – what has happened and what lies ahead

2021 ◽  
Vol 61 (2) ◽  
pp. 442
Author(s):  
Joelle Mitchell ◽  
Derrick O'Keeffe
Keyword(s):  
Disease Transmission ◽  
Management Strategies ◽  
Petroleum Industry ◽  
Initial Response ◽  
Control Measures ◽  
Supply Chain Disruptions ◽  
Infection Control Measures ◽  
Risk Management Strategies ◽  
The Impact ◽  
Offshore Petroleum

This study will provide a longitudinal account of how the Australian offshore petroleum industry has responded to the COVID-19 pandemic, and how the response has evolved over time, and will provide a regulatory perspective on the future challenges arising from the changes that have occurred during the industry in response to the pandemic. Since March 2020, the National Offshore Safety and Environmental Management Authority has been actively collecting information about the approach taken by the offshore petroleum industry to respond to the COVID-19 pandemic. The initial response focused on infectious disease control measures, identifying strategies to prevent disease transmission on offshore facilities and to respond should an outbreak occur offshore. The next phase considered the potential consequences of the infection control measures on facility safety and integrity, including the impact of reduced personnel on board on safety critical maintenance activities and emergency response capability, assurance of competence profile requirements being sustained on facilities, the long-term consequences of delayed routine maintenance, supply chain disruptions and access to specialist workforce. It became apparent that a rapid recovery to pre-COVID-19 conditions was unlikely, and the impacts would likely continue for some time; and psychosocial and fatigue risk management strategies were explored. Data collection methods included: surveys of operators, workplace inspections, review of documents and records, interviews with members of the workforce and participation in industry working groups.

Control of Nosocomial Clostridium difficile Transmission in Bone Marrow Transplant Patients

2000 ◽  
Vol 21 (3) ◽  
pp. 226-228 ◽  
Author(s):  
Hend Hanna ◽  
Issam Raad ◽  
Virginia Gonzalez ◽  
Jan Umphrey ◽  
Jeffrey Tarrand ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Bone Marrow Transplantation ◽  
Clostridium Difficile ◽  
Infection Control ◽  
Cancer Patients ◽  
Tertiary Care ◽  
Marrow Transplant ◽  
Control Measures ◽  
Transplant Patients ◽  
Infection Control Measures

AbstractThis is a report of six cases of Clostridium difficile-associated diarrhea (CDAD) that occurred among cancer patients undergoing bone marrow transplantation in a tertiary-care cancer hospital. Specific infection control measures that were taken to minimize the nosocomial spread of CDAD also are discussed.

scholarly journals What every orthopaedic surgeon should know about COVID-19: A review of the current literature

2020 ◽  
Vol 28 (2) ◽  
pp. 230949902092349 ◽  
Author(s):  
Colin Shing-Yat Yung ◽  
Kevin Chi Him Fok ◽  
Ching Ngai Leung ◽  
Yat Wa Wong
Keyword(s):  
Infection Control ◽  
Current Literature ◽  
Clinical Work ◽  
Control Measures ◽  
Orthopaedic Surgeon ◽  
Medical Community ◽  
Basic Information ◽  
Infection Control Measures ◽  
The World ◽  
Emerging Treatments

The coronavirus (COVID-19) pandemic has severely affected the medical community and stopped the world in its tracks. This review aims to provide the basic information necessary for us, orthopaedic surgeons to prepare ourselves to face this pandemic together. Herein, we cover the background of COVID-19, presentation, investigations, transmission, infection control and touch upon emerging treatments. It is of paramount importance that we should stay vigilant for our patients, our families and ourselves. Adequate infection control measures are necessary during day-to-day clinical work.

scholarly journals Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients undergoing Radiotherapy in Wuhan

2020 ◽  
Author(s):  
Conghua Xie ◽  
Xiaoyong Wang ◽  
Hui Liu ◽  
Zhirong Bao ◽  
Jing Yu ◽  
...  
Keyword(s):  
Infection Control ◽  
Head And Neck ◽  
Cancer Patients ◽  
Healthcare Worker ◽  
Healthcare Workers ◽  
Virus Disease ◽  
Hubei Province ◽  
Control Measures ◽  
Infection Control Measures ◽  
Corona Virus

AbstractBackgroundA pandemic of 2019 novel corona virus disease (COVID-19), which was first reported in Wuhan city, has affected more than 100,000 patients worldwide. Patients with cancer are at a higher risk of COVID-19, but currently, there is no guidance on the management of cancer patients during this outbreak. Here, we report the infection control measures and early outcomes of patients who received radiotherapy (RT) at a tertiary cancer centre in Wuhan.MethodsWe reviewed all patients who were treated at the Zhongnan Hospital of Wuhan University (ZHWU) from Jan 20 to Mar 6, 2020. This preceded the city lock-down date of Jan 23, 2020. Infection control measures were implemented, which included a clinical pathway for managing suspect COVID-19 cases, on-site screening, modifications to the RT facility, and protection of healthcare workers. Primary end-point was infection rate among patients and healthcare staff. Diagnosis of COVID-19 was based on the 5th edition criteria.Findings209 patients completed RT during the study period. Median age was 55 y (IQR = 48-64). Thoracic, head and neck, and lower gastrointestinal and gynaecological cancer patients consisted the majority of patients. Treatment sites included thoracic (38.3%), head and neck (25.4%), and abdomen and pelvis (25.8%); 47.4%, 27.3%, and 25.4% of treatments were for adjuvant, radical, and palliative indications, respectively. 188 treatments/day were performed prior to the lock-down, in contrast to 12.4 treatments/day post-lock-down. Only one (0.48%) patient was diagnosed with COVID-19 during the study period. No healthcare worker was infected.InterpretationHerein, we show that in a susceptible population to COVID-19, strict infection control measures can curb human-to-human transmission, and ensure timely delivery of RT to cancer patients.FundingThis study was funded by Health Commission of Hubei Province Scientific Research Project, WJ2019H002, Health Commission of Hubei Province Medical Leading Talent Project.Research in contextEvidence before this studyThe 2019 novel coronavirus disease (COVID-19) is now a global pandemic. Cancer patients are at risk of COVID-19 pneumonia, and thus infection control measures are crucial to mitigate their risk of infection. We searched PubMed and Medline for articles published up to Mar 12, 2020, using the following keywords: “COVID-19”, “SARS”, “SARS-CoV-2”, “infection control”, and “cancer”. No evidence exists that informs on the appropriate infection control measures for COVID-19.Added value of this studyWe report our single centre experience on the detailed infection control measures that were undertaken to minimise cross transmission between cancer patients undergoing radiotherapy, and between patients and healthcare workers. Measures entailing screening of suspect cases, re-organisation of the treatment facility, and protection of healthcare workers were described. With our infection control protocol, we recorded only one COVID-19 case among the 209 patients (0.48%) who were treated at our centre during the period of Jan 20 to Mar 6, 2020. No healthcare worker was affected.Implications of all the available evidenceThe effective infection control measures outlined in this study will help institutions worldwide affected by COVID-19 to formulate guidelines to mitigate nosocomial human-to-human transmission, especially among susceptible patients.

scholarly journals Reducing Intervention in the COVID-19 Era: Opportunities for Vital Pulp Treatment

2021 ◽  
Vol 2 ◽  
Author(s):  
Ikhlas A. El karim ◽  
Henry F. Duncan
Keyword(s):  
Management Strategies ◽  
Working Environment ◽  
Control Measures ◽  
Infection Control Measures ◽  
Dental Procedures ◽  
Relieve Pain ◽  
Multiple Visit ◽  
Simple Alternative ◽  
Global Health Problem ◽  
Pulp Treatment

Over the last 12 months, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) virus has emerged as a significant global health problem with extensive repercussions for the practise of dentistry. As the principle transmission-route is via droplet-spread, aerosol-generating dental procedures (AGPs) present an exquisite challenge, which either has to be avoided or performed using strict infection-control measures, which increase the deployment of resources and cost. This new working environment necessitates the adoption of simplified, yet effective procedures that reduce intervention and minimise clinical chair time to short, single visits. Vital pulp treatment (VPT) has emerged as an attractive, technically less-complicated group of biologically-based management strategies that are aimed at maintaining pulp vitality and avoiding root canal treatment (RCT). These procedures are carried out in a strict aseptic environment using a rubber dam and have a reported high success rate, suggesting that they could be considered as effective and simple alternative therapies to relieve pain and avoid multiple visit RCT and other endodontic procedures. The relevance of promoting a simple, predictable and effective alternative to traditional, more complex dentistry has never been more compelling. In this perspective article, the latest advances in VPT are highlighted, along with an analysis of their relative success and compelling reasons why we as dentists should be adopting these treatment approaches. Thereafter, case selection, prognostic factors, techniques, limitations and future prospects of these procedures are discussed.

Risk Factors for Venous Thromboembolism In Hospitalized Cancer Patients with Central Catheters

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 810-810 ◽  
Author(s):  
Emma C. Scott ◽  
Kathryn Schmidt Hudson ◽  
Scott Trerotola ◽  
Heather Smith ◽  
David Porter ◽  
...  
Keyword(s):  
Risk Factors ◽  
Regression Analysis ◽  
Infection Control ◽  
Cancer Patients ◽  
Multivariate Regression ◽  
Multivariate Regression Analysis ◽  
Hematologic Malignancies ◽  
Control Measures ◽  
Vte Prophylaxis ◽  
Infection Control Measures

Abstract Abstract 810 Background: The incidence of venous thromboembolism (VTE) and central venous catheter (CVC) related thrombosis is increased in cancer patients, in particular those with advanced hematologic malignancies. Bloodstream infection (BSI) is thought to increase CVC associated thrombosis in several small studies. In July 2007, systematic changes including intensive education, process changes and use of the Biopatch.. (Ethicon 360) were effective in decreasing the incidence of BSI (from 3% to 0.7%) at the Hospital of the University of Pennsylvania (HUP). Our primary objective was to identify risk factors for VTE in hospitalized cancer patients, particularly hematologic malignancy and stem cell transplant (SCT) patients. Secondary objectives were to evaluate the effect of VTE prophylaxis and infection control measures in preventing VTE and CVC thromboses and describe treatment strategies in this population. Methods: After IRB approval was obtained, patients admitted to oncology floors were identified using an inpatient database. This was cross-referenced with an Interventional Radiology Hickman catheter placement database. Demographic and clinical data were retrieved retrospectively from the electronic medical record (EMR). Clinical events including objectively documented VTE were confirmed by review of the EMR by investigators. A case-control study was performed. Odds ratios were calculated for risk factors associated with thrombosis and univariate and multivariate regression analysis was performed. Results: Between July 1, 2005 and June 30, 2009, 770 oncology inpatients had a tunneled catheter placed. 50 patients with a VTE after the CVC was placed were identified as cases. 182 controls without VTE were identified randomly. Mean patient age with and without VTE was 52 and 53 years respectively. Women constituted 42% and 41% of patients with and without VTE. Diagnoses in cases include leukemia in 33 (66%), lymphoma in 7 (14%), myeloma in 4 (8%), MDS and aplastic anemia in 1 each (4%) and solid tumor in 4 (8%). Types of SCT in cases were allogeneic in 16 (62%), non-myeloablative in 4 (15%) and autologous in 6 (23%). Of the 50 cases, 15 (31%) had multiple VTEs, 26 (52%) were CVC associated, 17 (34%) were DVT and 4 (8%) were PE. No VTE prophylaxis was used in 22 (47%) of cases. Median platelet count at time of thrombosis was 86. Anticoagulant therapy was used in 33 patients (67%), including UFH in 28 (85%) and LMWH in 5 (15%). Bleeding during anticoagulation occurred in 4 cases (12%). With regard specifically to CVC thrombosis, 13 (50%) cases presented before infection control measures were put in place, and 13 (50%) after, vs. controls (38% before and 62% after) (p= 0.23). BSI was present in 16 (62%) cases and 51 (28%) of controls (p = 0.27). In a SCT subset analysis, VTE occurred in 26 (31%) of 83 SCT patients vs. 25 (17%) of 150 nonSCT patients (p=0.01); CVC thrombosis occurred in 14 (20%) SCT patients vs. 12 (9%) nonSCT patients (p=0.02). Risk factors for venous thrombosis by univariate analysis include: In multivariate regression analysis, the following risk factors remained statistically significant: status post SCT (p = 0.001); obesity (p = 0.02); line type- PICC (p = 0.02); CVC not in the internal jugular (IJ) vein (p=0.03), and CVC tip not in the superior vena cava (SVC) (p=0.003). Conclusions: Subjects with a history of VTE, obesity, advanced hematologic malignancies and SCT recipients were more likely to develop a VTE. Active chemotherapy did not increase the risk of VTE. CVC related risk factors include left sided placement, non- IJ vessel, and tip not in the SVC. While the presence of BSI was minimally associated with CVC- thrombosis, use of infection control measures did not significantly reduce VTE risk. VTE prophylaxis appears to be effective in preventing VTE; however 47% of cases were not on any, suggesting that at least mechanical measures may be warranted in high risk patients. Thrombocytopenia is not protective against VTE and should not preclude prophylaxis in these patients. Additional studies are warranted to further define risk factors for VTE in this population. Disclosures: Trerotola: Bard: Consultancy; MedComp: Consultancy; Cook: Consultancy; Teleflex: Consultancy; Grant Adler: Consultancy.

Coronavirus: Towards controlling of the pandemic - Indian scenario

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 462-468
Author(s):  
Latika kothari ◽  
Sanskruti Wadatkar ◽  
Roshni Taori ◽  
Pavan Bajaj ◽  
Diksha Agrawal
Keyword(s):  
Control Measures ◽  
The Novel ◽  
Medical Treatments ◽  
Health Crisis ◽  
The Public ◽  
Infection Control Measures ◽  
The Social ◽  
Asking Questions ◽  
The Government ◽  
Novel Coronavirus

Coronavirus disease 2019 (COVID-19) is a communicable infection caused by the novel coronavirus resulting in severe acute respiratory syndrome coronavirus 2 (SARS-CoV). It was recognized to be a health crisis for the general population of international concern on 30th January 2020 and conceded as a pandemic on 11th March 2020. India is taking various measures to fight this invisible enemy by adopting different strategies and policies. To stop the COVID-19 from spreading, the Home Affairs Ministry and the health ministry, of India, has issued the nCoV 19 guidelines on travel. Screening for COVID-19 by asking questions about any symptoms, recent travel history, and exposure. India has been trying to get testing kits available. The government of India has enforced various laws like the social distancing, Janata curfew, strict lockdowns, screening door to door to control the spread of novel coronavirus. In this pandemic, innovative medical treatments are being explored, and a proper vaccine is being hunted to deal with the situation. Infection control measures are necessary to prevent the virus from further spreading and to help control the current situation. Thus, this review illustrates and explains the criteria provided by the government of India to the awareness of the public to prevent the spread of COVID-19.

Sign in / Sign up

Export Citation Format

Share Document